We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 437

Genetic technologies settles infringement suit over non-DNA coding technology
  • Shook Hardy & Bacon LLP
  • USA
  • May 2 2013

Genetic Technologies Ltd. (GTG) has reportedly settled a patent infringement lawsuit filed in late 2012 against PreventionGenetics. While the terms


Damage calculations best left for expert discovery
  • Shook Hardy & Bacon LLP
  • USA
  • April 29 2013

The Bosch court reasonably concluded that details relating to the calculation of a patent owner’s reasonable royalty and lost profits damages were


"Arising under" jurisdiction put asunder? Supreme Court adds strokes to "Jackson Pollock" canvas
  • Shook Hardy & Bacon LLP
  • USA
  • April 30 2013

The "unruly" arising-under doctrine of federal jurisdiction is in a state of "general confusion," according to the U.S. Supreme Court. The Court


Limits to look at licenses
  • Shook Hardy & Bacon LLP
  • USA
  • September 23 2013

The magistrate judge in Barnes and Noble limited a Plaintiff’s discovery request aimed at examining all of Defendant’s licenses to only those


U.S. Supreme Court opens door to fees in patent assertion entity litigation
  • Shook Hardy & Bacon LLP
  • USA
  • May 1 2014

The U.S. Supreme Court has unanimously ruled that the Federal Circuit Court of Appeals erred in reviewing de novo a district court "exceptional" case


Recent Apple filings reveal it’s a favorite PAE target
  • Shook Hardy & Bacon LLP
  • USA
  • February 13 2014

According to a news source, recent Apple filings with the U.S. Supreme Court and Federal Trade Commission (FTC) include details about the law suits


Myriad Genetics, gene by gene settle BRCA infringement dispute
  • Shook Hardy & Bacon LLP
  • USA
  • February 13 2014

According to a joint news release, Myriad Genetics, Inc. and other owners of the BRCA1 and BRCA2 gene patents have settled patent infringe- ment


Federal Circuit rules on zero damages and standard-essential patents
  • Shook Hardy & Bacon LLP
  • USA
  • May 1 2014

In a closely watched case, a divided Federal Circuit Court of Appeals panel has determined that U.S. Circuit Judge Richard Posner, presiding as a


Indian Supreme Court rules Novartis cancer drug change not patentable
  • Shook Hardy & Bacon LLP
  • India
  • April 4 2013

The Supreme Court of India has rejected the patent application filed by Novartis AG for a beta crystalline form of its cancer drug Gleevec, also


News Bytes - April 4, 2013
  • Shook Hardy & Bacon LLP
  • USA
  • April 4 2013

The U.S. Food and Drug Administration (FDA) issues draft guidance titled "Formal Meetings Between the FDA and Biosimilar Biological Product Sponsors